Plasma phosphorylated tau‐217 exhibits sex‐specific prognostication of cognitive decline and brain a...
Plasma phosphorylated tau‐217 exhibits sex‐specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults
About this item
Full title
Author / Creator
Saloner, Rowan , VandeVrede, Lawren , Asken, Breton M. , Paolillo, Emily W. , Gontrum, Eva Q. , Wolf, Amy , Lario‐Lago, Argentina , Milà‐Alomà, Marta , Triana‐Baltzer, Gallen , Kolb, Hartmuth C. , Dubal, Dena B. , Rabinovici, Gil D. , Miller, Bruce L. , Boxer, Adam L. , Casaletto, Kaitlin B. and Kramer, Joel H.
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
INTRODUCTION
Accumulating evidence indicates disproportionate tau burden and tau‐related clinical progression in females. However, sex differences in plasma phosphorylated tau (p‐tau)217 prediction of subclinical cognitive and brain changes are unknown.
METHODS
We measured baseline plasma p‐tau217, glial fibrillary acidic protein (GFAP), a...
Alternative Titles
Full title
Plasma phosphorylated tau‐217 exhibits sex‐specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10843677
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10843677
Other Identifiers
ISSN
1552-5260,1552-5279
E-ISSN
1552-5279
DOI
10.1002/alz.13454
